The MASC Trials 2021 Virtual Annual Scientific Meeting will bring together leading figures in clinical trials to share ideas and foster further innovative research. The program will feature presentations on…
The PaCCSC (Palliative Care Clinical Studies Collaborative) and CST (Cancer Symptom Trials) Annual Research Forum will be held on 17 and 18 March 2022. Under the theme Clinical trials: new…
The annual Victorian Centre for Biostatistics (ViCBiostat) Summer School will be held online again in 2022. Join the ViCBiostat team and international guest presenter Stijn Vansteelandt, for 2 weeks of…
NHMRC CEO, Prof Anne Kelso AO will discuss NHMRC’s analysis of funding outcomes by gender for the Investigator Grant scheme and potential interventions to reduce gender disparities in the scheme….
Planning for ACTA’s forthcoming website upgrade and expansion includes exploring the best options for a members’ community forum. We are considering everything from a fully featured forum with moderated sub-fora…
…https://clinicaltrialsalliance.org.au/membership/ We hope you enjoyed attending our events earlier in the year but, to comply with social distancing measures that are keeping our communities safe, future events will be web-based….
…in thoracic oncology. Register Now For more details about the ALTG and upcoming events please view the website https://altg.com.au/ The recording of the webinar will be available after the live event….
The PaCCSC and CST Annual Research Forum is our principal annual event. Past forums have supported new study ideas, provided networking opportunities and forged new collaborations. We’re back in 2021…
…an interim analysis that showed the following: Risk of serious AIDS events and deaths due to non-AIDS events including major cardiovascular events, renal and liver disease and cancer was reduced…
You’ll be reading this because you are more or less immersed in the investigator-initiated clinical trials sector zeitgeist. And that means you know that we should be doing everything we…
ACTA 2019 Summer School events In collaboration with ACTA’s Innovative Trial Design Reference Group, a range of educational workshops and seminars were held online and in Melbourne, Sydney and Brisbane…
The ASPirin in Reducing Events in the Elderly (ASPREE) Study won ACTA’s 2019 ‘Trial of the Year’ Award after finding that low-dose aspirin did not increase the time which over…
Where? The University of Sydney Business School’s Abercrombie Building When? 4:30 – 5:30 PM, 28 November 2018 on the eve of the ACTA Summit Who’s it for? ACTA Members will…
ACTA welcomes back Adaptive Trial design expert Scott Berry to provide an overview on FDA guidance released for Adaptive Designs for Clinical Trials of Drugs and Biologics. You can download a copy…
Meeting Room 216, Convention Centre Level 2, Melbourne Convention and Exhibition Centre This meeting is open only to our Full and Associate Members. Please contact ACTA Central for further details…
Meeting Room 216, Convention Centre Level 2, Melbourne Convention and Exhibition Centre This meeting is only open to our Full and Associate Members. For further information, contact ACTA; info@clinicaltrialsalliance.org.au…
Super webinar On Tuesday 11 February 2020 ACTA held its biggest webinar to date—the Super Webinar to disseminate and open communication around a guidance document ACTA has created to guide trialists towards optimising…
Designing innovative trials, including Bayesian adaptive trials, was a hot topic at this years’ 2019 ACTA International Clinical Trials Conference in Sydney. We are pleased to announce that a Bayesian…
Melbourne, Thursday 21 November to Monday 25 November With major support from the Melbourne Academic Centre for Health (MACH) and co-sponsorship from Monash Partners and Australian Clinical Trials Alliance, ViCBiostat is conducting…
Australasian Gastro-Intestinal Trials Group 22nd Annual Scientific Meeting Online meeting Convenor: Professor Stephen Ackland The AGITG Annual Scientific Meeting serves not only as a forum for the presentation of state-of-the art overviews…
This workshop will be held on the 27–28 February 2020 in Melbourne and 5-6 March 2020 in Sydney. Presenters will include international experts A/Prof Lorenzo Trippa and Dr Steffen Ventz,…
This workshop will be held on the 27–28 February 2020 in Melbourne and 5-6 March 2020 in Sydney. Presenters will include international experts A/Prof Lorenzo Trippa and Dr Steffen Ventz,…
A workshop on Bayesian adaptive randomised trials, delivered by international leaders in this field; Dr Lorenzo Trippa and Dr Steffen Ventz. Update: This event is now sold-out. Please register for…
The number of clinical trials in Australia that are using adaptive methods is increasing. ACTA Innovative Trial Design Reference Group and ACTA STInG leadership group are heavily involved in…
Two half days: Tuesday 19 and Wednesday 20 May Workshop via webinar ACTA’s Innovative Outcome Data reference group is hosting a virtual workshop across two half-days for key stakeholders to…
Join co-hosts PRAXIS and ACTA on twitter for a short series of tweetchats focussed on COVID-19 support and information exchange for clinical trials. Use the hashtag #WhyWeDoResearch on Tuesday 28 April and…
While no-one can predict the broader impacts of the Covid-19 pandemic confidently, it seems likely that a sense of uncertainty will be with us for some time to come. This uncertainty will spread through…
Clinical Trials are conducted to collect the data necessary to provide information about the safety and efficacy of new treatments and interventions, that ensure that we as a society receive access to high quality,…
ACTA and Anne McKenzie AM, are hosting a virtual training workshop on implementing consumer and community involvement in clinical trials. The purpose of the workshop is to build skills, confidence…
ACTA and Anne McKenzie AM, are hosting a virtual training workshop on implementing consumer and community involvement in clinical trials. The purpose of the workshop is to build skills, confidence…
The Continuity of Care Collaboration (CCC) is an Australian-first national communication collaboration of more than 35 peak bodies (including ACTA), industry and healthcare organisations. They are working together to highlight…